Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD
Jonathan C. Poe(Duke University), Stefanie Sarantopoulos(Duke University), Mitchell E. Horwitz(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sonali J. Bracken(UConn Health), Kathy S. Wang(Dana-Farber Cancer Institute), Marissa R. Lee(Duke University), Amy N. Suthers(Duke Medical Center), Rachel A. DiCioccio(Cellular Therapeutics (United Kingdom)), Jennifer Zhang(Bristol-Myers Squibb (Germany)), Kouros Owzar(Duke University), Vincent T. Ho(Dana-Farber Cancer Institute), Nelson J. Chao(Duke University), Jonathan Visentin(Centre National de la Recherche Scientifique), Jichun Xie(University of Minnesota), Wei Jia(LMU Klinikum), David A. Rizzieri(Duke University), Frances T. Hakim(National Cancer Institute), Adela R. Cardones(Duke Medical Center), Steven Z. Pavletic(National Institutes of Health), William C. McManigle(Cellular Therapeutics (United Kingdom)), Jiyuan Fang(Duke University), Itaevia Curry-Chisolm(Cellular Therapeutics (United Kingdom)), Hsuan Su(Duke Medical Center), Jeremy J. Rose(National Institutes of Health), Dadong Zhang(Duke Cancer Institute), Xiaodi Qin(Duke Cancer Institute)
Cited by 21
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k